NO20013698L - Fremgangsmåte for identifisering av N-terminalt proBNP - Google Patents

Fremgangsmåte for identifisering av N-terminalt proBNP

Info

Publication number
NO20013698L
NO20013698L NO20013698A NO20013698A NO20013698L NO 20013698 L NO20013698 L NO 20013698L NO 20013698 A NO20013698 A NO 20013698A NO 20013698 A NO20013698 A NO 20013698A NO 20013698 L NO20013698 L NO 20013698L
Authority
NO
Norway
Prior art keywords
bnp
terminal pro
identifying
terminal probnp
recombinant
Prior art date
Application number
NO20013698A
Other languages
English (en)
Other versions
NO329866B1 (no
NO20013698D0 (no
Inventor
Johann Karl
Helmut Lill
Peter Stahl
Kerstin Krueger
Anneliese Borgya
Andreas Gallusser
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20013698D0 publication Critical patent/NO20013698D0/no
Publication of NO20013698L publication Critical patent/NO20013698L/no
Publication of NO329866B1 publication Critical patent/NO329866B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of Radiation (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
NO20013698A 1999-01-29 2001-07-27 Fremgangsmate for pavisning av nativt N-terminalt proBNP i en prove som utfores i "sandwich"-format ved anvendelse av minst to antistoffer som gjenkjenner forskjellige epitoper i det native N-terminale proBNP, og som samtidig kan bindes til nativt N-terminalt proBNP, anvendelse av fremgangsmaten for differensiering mellom prover, anvendelse av rekombinant N-terminalt proBNP som standard i en fremgangsmate, antistoffer mot N-terminalt proBNP fremstilt ved immunisering av en egnet organisme med rekombinant fremstilt N-terminalt proBNP, samt cellelinje. NO329866B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903489 1999-01-29
DE19911044 1999-03-12
PCT/EP2000/000602 WO2000045176A2 (de) 1999-01-29 2000-01-27 VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP

Publications (3)

Publication Number Publication Date
NO20013698D0 NO20013698D0 (no) 2001-07-27
NO20013698L true NO20013698L (no) 2001-09-28
NO329866B1 NO329866B1 (no) 2011-01-17

Family

ID=26051550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013698A NO329866B1 (no) 1999-01-29 2001-07-27 Fremgangsmate for pavisning av nativt N-terminalt proBNP i en prove som utfores i "sandwich"-format ved anvendelse av minst to antistoffer som gjenkjenner forskjellige epitoper i det native N-terminale proBNP, og som samtidig kan bindes til nativt N-terminalt proBNP, anvendelse av fremgangsmaten for differensiering mellom prover, anvendelse av rekombinant N-terminalt proBNP som standard i en fremgangsmate, antistoffer mot N-terminalt proBNP fremstilt ved immunisering av en egnet organisme med rekombinant fremstilt N-terminalt proBNP, samt cellelinje.

Country Status (21)

Country Link
US (1) US20070059767A1 (no)
EP (2) EP1698901B1 (no)
JP (1) JP3987284B2 (no)
KR (1) KR100572542B1 (no)
CN (2) CN101046478B (no)
AT (2) ATE373826T1 (no)
AU (1) AU758562B2 (no)
CA (1) CA2359667C (no)
CY (1) CY1108450T1 (no)
DE (2) DE50014666D1 (no)
DK (2) DK1698901T3 (no)
ES (2) ES2292426T3 (no)
HU (1) HU228625B1 (no)
IL (2) IL144062A0 (no)
NO (1) NO329866B1 (no)
NZ (1) NZ512762A (no)
PL (1) PL204235B1 (no)
PT (1) PT1698901E (no)
RU (1) RU2218568C2 (no)
WO (1) WO2000045176A2 (no)
ZA (1) ZA200106193B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004105A (es) 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
GB0216191D0 (en) * 2002-07-11 2002-08-21 Univ Leicester Plasma urotensin in human heart failure
FR2843396B1 (fr) 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US6960472B2 (en) * 2002-11-18 2005-11-01 Ottawa Heart Institute Research Corporation Monoclonal antibodies against N-Terminus proBNP
US20040096919A1 (en) 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
JP4610025B2 (ja) * 2002-11-18 2011-01-12 シン．クス ファーマ、インコーポレイテッド ＮＴ−ｐｒｏＢＮＰ検出用ポリクローナル・モノクローナル・エライサ検定法
US20050287613A1 (en) * 2002-11-18 2005-12-29 George Jackowski Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
ATE335763T1 (de) * 2002-11-20 2006-09-15 Brahms Ag Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
US7767419B2 (en) * 2003-02-04 2010-08-03 Nexus Dx, Inc. Calibrator for NT-proBNP immunoassay
CA2522747C (en) 2003-05-12 2012-08-14 F. Hoffmann-La Roche Ag Method of detecting native probnp with a monoclonal antibody binding to the amino acids 38-43
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
DE10355731A1 (de) 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
GB0329288D0 (en) 2003-12-18 2004-01-21 Inverness Medical Switzerland Monitoring method and apparatus
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FR2863269B1 (fr) * 2005-01-14 2006-05-26 Bio Rad Pasteur Peptides specifiques pour le diagnostic de l'insuffisance cardiaque
DE102005003687A1 (de) * 2005-01-26 2006-07-27 Sphingo Tec Gmbh Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
EP1722232A1 (en) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
EP1909206A1 (de) * 2006-09-11 2008-04-09 Roche Diagnostics GmbH Messbereichserweiterung chromatografischer Schnellteste
EP1909207B1 (de) * 2006-09-11 2015-03-04 F.Hoffmann-La Roche Ag Messbereichserweiterung chromatografischer Schnellteste
DE102006060835A1 (de) * 2006-12-22 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP
EP2498095A3 (en) * 2007-01-25 2012-11-28 Roche Diagniostics GmbH Use of IGFBP-7 in the assessment of heart failure
ES2430290T3 (es) * 2007-03-06 2013-11-19 F. Hoffmann-La Roche Ag Utilización de péptidos de tipo PNC para predecir la necesidad de diálisis
EP2145184B1 (en) 2007-03-08 2013-10-02 Roche Diagnostics GmbH Use of slim-1 in the assessment of heart failure
WO2009027514A1 (en) * 2007-08-30 2009-03-05 Roche Diagnostics Gmbh Means and methods for the discrimination of gdf-15 elevation related or unrelated to cardiac disorders
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
WO2011012268A1 (en) 2009-07-27 2011-02-03 Roche Diagnostics Gmbh Use of mimecan in the assessment of heart failure
US11493507B2 (en) * 2009-09-14 2022-11-08 Siemens Healthineers Nederland B.V. Highly sensitive immunoassay with large particle labels
CN101819205A (zh) * 2010-06-03 2010-09-01 中国人民解放军第三军医大学 人n端b型利钠肽原免疫分析试剂盒及其制备方法
EP2601531A1 (en) * 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Detection of degradation products of canine nt-probnp
US8481333B2 (en) 2011-05-31 2013-07-09 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
CN102692512A (zh) * 2012-06-26 2012-09-26 南京基蛋生物科技有限公司 NT-proBNP双抗夹心快速检测试剂盒
CN109678958B (zh) * 2019-01-31 2022-03-18 重庆探生科技有限公司 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用
WO2021028520A1 (en) 2019-08-13 2021-02-18 Gentian As Highly sensitive particle enhanced assay for the quantification of nt-probnp
WO2023052642A1 (en) 2021-10-01 2023-04-06 Gentian As Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
DE3509958A1 (de) * 1985-03-20 1986-09-25 Bayer Ag, 5090 Leverkusen Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
JP5254997B2 (ja) * 2007-01-26 2013-08-07 テレフオンアクチーボラゲット エル エム エリクソン（パブル） 発見フレーム領域についての動き推定

Also Published As

Publication number Publication date
EP1698901A1 (de) 2006-09-06
HUP0105195A2 (hu) 2002-04-29
NO329866B1 (no) 2011-01-17
RU2218568C2 (ru) 2003-12-10
WO2000045176A3 (de) 2001-07-26
AU758562B2 (en) 2003-03-27
EP1151304A2 (de) 2001-11-07
CA2359667A1 (en) 2000-08-03
HU228625B1 (en) 2013-04-29
IL144062A (en) 2007-09-20
DK1151304T3 (da) 2008-01-28
CN101046478A (zh) 2007-10-03
JP3987284B2 (ja) 2007-10-03
CA2359667C (en) 2009-10-20
PL204235B1 (pl) 2009-12-31
CN101046478B (zh) 2013-04-03
ATE373826T1 (de) 2007-10-15
HUP0105195A3 (en) 2005-11-28
CN1327228C (zh) 2007-07-18
IL144062A0 (en) 2002-04-21
AU2545100A (en) 2000-08-18
ATE403158T1 (de) 2008-08-15
WO2000045176A2 (de) 2000-08-03
KR100572542B1 (ko) 2006-04-24
DE50015291D1 (de) 2008-09-11
KR20010101874A (ko) 2001-11-15
ES2312062T3 (es) 2009-02-16
EP1698901B1 (de) 2008-07-30
DE50014666D1 (de) 2007-10-31
NO20013698D0 (no) 2001-07-27
CY1108450T1 (el) 2014-04-09
US20070059767A1 (en) 2007-03-15
ES2292426T3 (es) 2008-03-16
NZ512762A (en) 2003-02-28
PT1698901E (pt) 2008-10-08
ZA200106193B (en) 2002-05-02
EP1151304B1 (de) 2007-09-19
DK1698901T3 (da) 2008-12-08
CN1339107A (zh) 2002-03-06
JP2003508724A (ja) 2003-03-04
PL364798A1 (en) 2004-12-13
EP1151304B9 (de) 2008-06-04

Similar Documents

Publication Publication Date Title
NO20013698D0 (no) Fremgangsmåte for identifisering av N-terminalt proBNP
PL1625163T3 (pl) Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
EP1139101A3 (en) Immunoassay for c-reactive protein
ATE333649T1 (de) Immunotestverfahren für herz-troponin i
SI1232392T1 (en) Improved method for the detection of acid resistant bacteria of the genus helicobacter in stool
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
DE69927255D1 (de) Verfahren zum nachweis des komplexes von igfbp-3 mit igf und/oder als
JP2007525427A5 (no)
DE3579841D1 (de) Multisites immunometrisches testverfahren.
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
ATE210680T1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
DK202189A (da) Monoklont antistof til selektiv immunologisk bestemmelse af intakt prokollagen-peptid (type iii) og prokollagen (type iii) i legemsvaesker
DE69112225D1 (de) Immunodiagnostische probe für gelenkrheumatismus.
EP1245957A3 (en) Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease
AU5039290A (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
Ishikawa et al. Novel and sensitive noncompetitive (two-site) immunoassay for haptens with emphasis on peptides
KR890012669A (ko) 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체
DE69919859D1 (de) Verfahren zum bestimmen eines überschäumfaktors für ein getränk
WO1999061477A3 (en) Monoclonal antibody and assay for detecting piiinp
DK329789D0 (da) Monoklonalt antistof
Englebienne et al. An improved method for isolation of specific antibodies by affinity chromatography; application to an antiserum to testosterone
ES8802263A1 (es) Procedimiento inmunologico para la determinacion de la hormona luteinizante
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees